EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Creotech Instruments EBITDA Margin % Related Terms
Creotech Instruments EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Creotech Instruments's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:CRI vs GE, RTX, BA: EBITDA Margin % Comparison
For the Aerospace & Defense subindustry, Creotech Instruments's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creotech Instruments EBITDA Margin % vs Aerospace & Defense Industry
For the Aerospace & Defense industry and Industrials sector, Creotech Instruments's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Creotech Instruments's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creotech Instruments (WAR:CRI) has a EBITDA Margin % of -36.48% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Creotech Instruments and its competitors. According to the industry distribution chart, Creotech Instruments ranks #86 out of 347 companies in the Aerospace & Defense industry, placing it in the top 24.8%.
Is Creotech Instruments' EBITDA Margin % too high?
Creotech Instruments' current EBITDA Margin % is -36.48%. Based on the distribution chart, Creotech Instruments ranks #86 out of 347 companies in the Aerospace & Defense industry, which is in the top quartile — a strong position relative to peers. Overall, Creotech Instruments has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' EBITDA Margin % compare to GE and RTX?
According to the Aerospace & Defense industry distribution chart, Creotech Instruments ranks #86 out of 347 companies for EBITDA Margin %. This places Creotech Instruments in the top 25% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 11.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Aerospace & Defense company?
The median EBITDA Margin % among Aerospace & Defense companies is 11.96, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Creotech Instruments and its competitors. For the Aerospace & Defense industry, the median EBITDA Margin % is 11.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creotech Instruments's current EBITDA Margin % is -36.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Fairly Valued. The stock's GF Value™ is zł752.35, compared to a current price of zł727.00 — trading 3.4% below its estimated fair value. The current EBITDA Margin % is -36.48%. Creotech Instruments' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current EBITDA Margin % is -36.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creotech Instruments (WAR:CRI) Overvalued in 2026?
Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued.
The current stock price of zł727.00 is trading 3.4% below its estimated GF Value™ of zł752.35.
GuruFocus considers Creotech Instruments to be Fairly Valued.
Key valuation signals for WAR:CRI:
EBITDA Margin %: -36.48%
GF Value™: zł752.35 vs. price of zł727.00 (3.4% below fair value)
No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
73GF Score
Get the complete analysis for WAR:CRI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CRI has been successfully added to your 
